2026年01月14日，朗信生物宣布旗下眼科基因治疗产品LX102Ⅲ期临床试验（STELLAR研究) ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to enable in vivo gene delivery, today announced that Roche (SIX: RO, ...

So I’ve been spendinga lot of time online lately, and not just for my usual searches for cool car videos and vintage pornography. If you’ve been following Project RX-8’s progress at all, then you know ...